These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17851563)

  • 1. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients.
    Wang J; Yang JW; Zeevi A; Webber SA; Girnita DM; Selby R; Fu J; Shah T; Pravica V; Hutchinson IV; Burckart GJ
    Clin Pharmacol Ther; 2008 May; 83(5):711-7. PubMed ID: 17851563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation.
    Kagaya H; Miura M; Saito M; Habuchi T; Satoh S
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):631-6. PubMed ID: 20136638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inosine monophosphate dehydrogenase polymorphisms and renal allograft outcome.
    Shah S; Harwood SM; Döhler B; Opelz G; Yaqoob MM
    Transplantation; 2012 Sep; 94(5):486-91. PubMed ID: 22960765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malnutrition Risk in Kidney Recipients Treated With Mycophenolate Mofetil Is Associated With IMPDH1 rs2278294 Polymorphism.
    Pazik J; Lewandowski Z; Nowacka Cieciura E; Ołdak M; Podgórska M; Sadowska A; Dęborska Materkowska D; Durlik M
    Transplant Proc; 2018; 50(6):1794-1797. PubMed ID: 30056902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of inosine monophosphate dehydrogenase activity and expression during the early period of mycophenolate mofetil therapy in de novo renal transplant patients.
    Molinaro M; Chiarelli LR; Biancone L; Castagneto M; Boschiero L; Pisani F; Sabbatini M; Sandrini S; Arbustini E; Tinelli C; Regazzi M; Schena FP; Segoloni GP
    Drug Metab Pharmacokinet; 2013; 28(2):109-17. PubMed ID: 22892445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte counts in kidney allograft recipients are associated with IMPDH2 3757T>C gene polymorphism.
    Pazik J; Ołdak M; Podgórska M; Lewandowski Z; Sitarek E; Płoski R; Szmidt J; Chmura A; Durlik M; Malejczyk J
    Transplant Proc; 2011 Oct; 43(8):2943-5. PubMed ID: 21996196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
    Winnicki W; Weigel G; Sunder-Plassmann G; Bajari T; Winter B; Herkner H; Sengoelge G
    Pharmacogenomics J; 2010 Feb; 10(1):70-6. PubMed ID: 19770842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of four DNA polymorphisms with acute rejection after kidney transplantation.
    Grinyó J; Vanrenterghem Y; Nashan B; Vincenti F; Ekberg H; Lindpaintner K; Rashford M; Nasmyth-Miller C; Voulgari A; Spleiss O; Truman M; Essioux L
    Transpl Int; 2008 Sep; 21(9):879-91. PubMed ID: 18444945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.
    Bremer S; Mandla R; Vethe NT; Rasmussen I; Rootwelt H; Line PD; Midtvedt K; Bergan S
    Transplantation; 2008 Jan; 85(1):55-61. PubMed ID: 18192912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients.
    Ohmann EL; Burckart GJ; Brooks MM; Chen Y; Pravica V; Girnita DM; Zeevi A; Webber SA
    J Heart Lung Transplant; 2010 May; 29(5):509-16. PubMed ID: 20061166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.
    Wang J; Zeevi A; Webber S; Girnita DM; Addonizio L; Selby R; Hutchinson IV; Burckart GJ
    Pharmacogenet Genomics; 2007 Apr; 17(4):283-90. PubMed ID: 17496727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation.
    Raggi MC; Siebert SB; Steimer W; Schuster T; Stangl MJ; Abendroth DK
    Transplantation; 2010 Dec; 90(12):1536-41. PubMed ID: 21076373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association of FOXP3 gene polymorphisms with allograft rejection in renal transplant patients.
    Qiu XY; Jiao Z; Zhang M; Chen JP; Shi XJ; Zhong MK
    Nephrology (Carlton); 2012 May; 17(4):423-30. PubMed ID: 22239151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients.
    Michelon H; König J; Durrbach A; Quteineh L; Verstuyft C; Furlan V; Ferlicot S; Letierce A; Charpentier B; Fromm MF; Becquemont L
    Pharmacogenomics; 2010 Dec; 11(12):1703-13. PubMed ID: 21142914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations in the mycophenolate mofetil target enzyme are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation.
    Cao W; Xiao H; Lai X; Luo Y; Shi J; Tan Y; Zheng W; He J; Xie W; Li L; Ye X; Yu X; Lin M; Cai Z; Huang H
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):273-9. PubMed ID: 21745452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India.
    Singh R; Kesarwani P; Ahirwar DK; Kapoor R; Mittal RD
    Transpl Immunol; 2009 May; 21(1):13-7. PubMed ID: 19189859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients.
    Zheng HX; Zeevi A; McCurry K; Schuetz E; Webber S; Ristich J; Zhang J; Iacono A; Dauber J; McDade K; Zaldonis D; Lamba J; Burckart GJ
    Transpl Immunol; 2005 Mar; 14(1):37-42. PubMed ID: 15814280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in IMPDH2, UGT2B7, and CES2 genes influence the risk of graft rejection in kidney transplant recipients taking mycophenolate mofetil.
    Cilião HL; Camargo-Godoy RBO; Souza MF; Zanuto A; Delfino VDA; Cólus IMS
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt B):97-102. PubMed ID: 30442353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.
    Wu TY; Peng Y; Pelleymounter LL; Moon I; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM
    Br J Pharmacol; 2010 Dec; 161(7):1584-98. PubMed ID: 20718729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.